Biodesix - 5 Year Stock Price History | BDSX
Historical daily share price chart and data for Biodesix since 2020 adjusted for splits and dividends. The latest closing stock price for Biodesix as of November 13, 2025 is 7.90.
- The all-time high Biodesix stock closing price was 624.20 on January 20, 2021.
- The Biodesix 52-week high stock price is 32.20, which is 307.6% above the current share price.
- The Biodesix 52-week low stock price is 3.44, which is 56.5% below the current share price.
- The average Biodesix stock price for the last 52 weeks is 12.89.
| Biodesix Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 10.9032 | 29.6000 | 29.8000 | 4.4000 | 7.9000 | -74.18% |
| 2024 | 31.6266 | 35.6000 | 42.4000 | 23.8000 | 30.6000 | -16.85% |
| 2023 | 32.5186 | 41.0000 | 50.0000 | 20.8000 | 36.8000 | -20.00% |
| 2022 | 40.8261 | 116.2000 | 116.2000 | 19.5000 | 46.0000 | -56.52% |
| 2021 | 268.0492 | 396.0000 | 624.2000 | 81.8000 | 105.8000 | -73.76% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.063B | $0.071B |
| Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.245B | 28.69 |
| HCA Healthcare (HCA) | United States | $108.000B | 17.88 |
| CVS Health (CVS) | United States | $100.590B | 11.57 |
| Elevance Health (ELV) | United States | $72.957B | 10.70 |
| Cencora (COR) | United States | $70.853B | 22.85 |
| Natera (NTRA) | United States | $27.695B | 0.00 |
| DiDi Global (DIDIY) | China | $25.933B | 21.19 |
| Labcorp Holdings (LH) | United States | $22.206B | 16.93 |
| Medpace Holdings (MEDP) | United States | $16.656B | 41.35 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.321B | 0.00 |
| ICON (ICLR) | Ireland | $13.200B | 13.10 |
| Solventum (SOLV) | United States | $13.047B | 12.66 |
| Viatris (VTRS) | United States | $12.566B | 4.68 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 19.50 |
| HealthEquity (HQY) | United States | $8.573B | 34.31 |
| Charles River Laboratories (CRL) | United States | $8.328B | 16.04 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.856B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.816B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.726B | 34.14 |
| Bausch + Lomb (BLCO) | Canada | $5.557B | 36.49 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.768B | 66.17 |
| Alignment Healthcare (ALHC) | United States | $3.356B | 0.00 |
| Concentras Parent (CON) | United States | $2.531B | 15.80 |
| Premier (PINC) | United States | $2.325B | 22.53 |
| Progyny (PGNY) | United States | $2.105B | 41.39 |
| Organon (OGN) | United States | $1.981B | 2.09 |
| Surgery Partners (SGRY) | United States | $1.980B | 25.52 |
| Pediatrix Medical (MD) | United States | $1.943B | 11.60 |
| Establishment Labs Holdings (ESTA) | $1.882B | 0.00 | |
| PACS (PACS) | United States | $1.631B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.255B | 0.00 |
| Omada Health (OMDA) | $1.203B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.042B | 17.06 |
| Embecta (EMBC) | United States | $0.843B | 4.93 |
| CareDx (CDNA) | United States | $0.816B | 13.34 |
| InnovAge Holding (INNV) | United States | $0.727B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.617B | 8.50 |
| Nutex Health (NUTX) | United States | $0.604B | 9.15 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.508B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.439B | 0.00 |
| Enhabit (EHAB) | United States | $0.412B | 18.52 |
| Strata Critical Medical (SRTA) | United States | $0.399B | 0.00 |
| So-Young (SY) | China | $0.365B | 0.00 |
| Pomdoctor - (POM) | China | $0.362B | 0.00 |
| SBC Medicals (SBC) | United States | $0.349B | 7.64 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| KindlyMD (NAKA) | United States | $0.275B | 0.00 |
| Agilon Health (AGL) | United States | $0.250B | 0.00 |
| LifeMD (LFMD) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| DocGo (DCGO) | United States | $0.102B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 6.84 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |